Unknown

Dataset Information

0

A Lipidomics- and Transcriptomics-Based Analysis of the Intestine of Genetically Obese (ob/ob) and Diabetic (db/db) Mice: Links with Inflammation and Gut Microbiota.


ABSTRACT: Obesity is associated with a cluster of metabolic disorders, chronic low-grade inflammation, altered gut microbiota, increased intestinal permeability, and alterations of the lipid mediators of the expanded endocannabinoid (eCB) signaling system, or endocannabinoidome (eCBome). In the present study, we characterized the profile of the eCBome and related oxylipins in the small and large intestines of genetically obese (ob/ob) and diabetic (db/db) mice to decipher possible correlations between these mediators and intestinal inflammation and gut microbiota composition. Basal lipid and gene expression profiles, measured by LC/MS-MS-based targeted lipidomics and qPCR transcriptomics, respectively, highlighted a differentially altered intestinal eCBome and oxylipin tone, possibly linked to increased mRNA levels of inflammatory markers in db/db mice. In particular, the duodenal levels of several 2-monoacylglycerols and N-acylethanolamines were increased and decreased, respectively, in db/db mice, which displayed more pronounced intestinal inflammation. To a little extent, these differences were explained by changes in the expression of the corresponding metabolic enzymes. Correlation analyses suggested possible interactions between eCBome/oxylipin mediators, cytokines, and bacterial components and bacterial taxa closely related to intestinal inflammation. Collectively, this study reveals that db/db mice present a higher inflammatory state in the intestine as compared to ob/ob mice, and that this difference is associated with profound and potentially adaptive or maladaptive, and partly intestinal segment-specific alterations in eCBome and oxylipin signaling. This study opens the way to future investigations on the biological role of several poorly investigated eCBome mediators and oxylipins in the context of obesity and diabetes-induced gut dysbiosis and inflammation.

SUBMITTER: Suriano F 

PROVIDER: S-EPMC9913869 | biostudies-literature | 2023 Jan

REPOSITORIES: biostudies-literature

altmetric image

Publications

A Lipidomics- and Transcriptomics-Based Analysis of the Intestine of Genetically Obese (<i>ob/ob</i>) and Diabetic (<i>db/db</i>) Mice: Links with Inflammation and Gut Microbiota.

Suriano Francesco F   Manca Claudia C   Flamand Nicolas N   Van Hul Matthias M   Delzenne Nathalie M NM   Silvestri Cristoforo C   Cani Patrice D PD   Di Marzo Vincenzo V  

Cells 20230125 3


Obesity is associated with a cluster of metabolic disorders, chronic low-grade inflammation, altered gut microbiota, increased intestinal permeability, and alterations of the lipid mediators of the expanded endocannabinoid (eCB) signaling system, or endocannabinoidome (eCBome). In the present study, we characterized the profile of the eCBome and related oxylipins in the small and large intestines of genetically obese (<i>ob/ob</i>) and diabetic (<i>db/db</i>) mice to decipher possible correlatio  ...[more]

Similar Datasets

| S-EPMC8240277 | biostudies-literature
| S-EPMC8826473 | biostudies-literature
| S-EPMC5866387 | biostudies-other
| S-EPMC8241037 | biostudies-literature
| S-EPMC2451047 | biostudies-other
| S-EPMC1152221 | biostudies-other
| S-EPMC1147215 | biostudies-other
| S-EPMC1164196 | biostudies-other
| S-EPMC1144591 | biostudies-other
| S-EPMC4454685 | biostudies-literature